Cubist Systematic Strategies’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-11,822
| Closed | -$535K | – | 3526 |
|
|
2024
Q2 | $535K | Buy |
11,822
+7,735
| +189% | +$356K | ﹤0.01% | 2098 |
|
|
2024
Q1 | $198K | Buy |
+4,087
| New | +$200K | ﹤0.01% | 3085 |
|
|
2023
Q4 | – | Sell |
-3,294
| Closed | -$193K | – | 4141 |
|
|
2023
Q3 | $193K | Buy |
3,294
+1,345
| +69% | +$84.1K | ﹤0.01% | 2800 |
|
|
2023
Q2 | $123K | Sell |
1,949
-6,628
| -77% | -$422K | ﹤0.01% | 2954 |
|
|
2023
Q1 | $539K | Buy |
+8,577
| New | +$512K | ﹤0.01% | 2616 |
|
|
2022
Q4 | – | Sell |
-20,291
| Closed | -$1.14M | – | 4613 |
|
|
2022
Q3 | $1.14M | Buy |
20,291
+1,946
| +11% | +$129K | 0.01% | 2518 |
|
|
2022
Q2 | $1.33M | Sell |
18,345
-19,452
| -51% | -$1.45M | 0.01% | 2237 |
|
|
2022
Q1 | $3M | Buy |
37,797
+17,083
| +82% | +$1.54M | 0.03% | 1145 |
|
|
2021
Q4 | $2.1M | Buy |
20,714
+15,050
| +266% | +$1.5M | 0.02% | 1325 |
|
|
2021
Q3 | $522K | Buy |
5,664
+2,569
| +83% | +$247K | 0.01% | 2009 |
|
|
2021
Q2 | $317K | Sell |
3,095
-2,960
| -49% | -$297K | ﹤0.01% | 2292 |
|
|
2021
Q1 | $591K | Buy |
6,055
+727
| +14% | +$66.2K | 0.01% | 1866 |
|
|
2020
Q4 | $411K | Sell |
5,328
-16,928
| -76% | -$1.31M | 0.01% | 1881 |
|
|
2020
Q3 | $1.64M | Sell |
22,256
-34,960
| -61% | -$2.8M | 0.02% | 1025 |
|
|
2020
Q2 | $4.2M | Buy |
57,216
+32,167
| +128% | +$2.52M | 0.07% | 420 |
|
|
2020
Q1 | $1.45M | Buy |
25,049
+21,337
| +575% | +$1.48M | 0.04% | 623 |
|
|
2019
Q4 | $292K | Sell |
3,712
-10,534
| -74% | -$776K | 0.01% | 1851 |
|
|
2019
Q3 | $974K | Sell |
14,246
-5,446
| -28% | -$366K | 0.02% | 981 |
|
|
2019
Q2 | $1.56M | Sell |
19,692
-13,503
| -41% | -$1.07M | 0.03% | 800 |
|
|
2019
Q1 | $2.78M | Buy |
33,195
+30,703
| +1,232% | +$3.2M | 0.09% | 313 |
|
|
2018
Q4 | $293K | Sell |
2,492
-4,468
| -64% | -$517K | 0.01% | 1295 |
|
|
2018
Q3 | $839K | Sell |
6,960
-4,342
| -38% | -$539K | 0.05% | 544 |
|
|
2018
Q2 | $1.3M | Sell |
11,302
-16,907
| -60% | -$1.85M | 0.07% | 376 |
|
|
2018
Q1 | $2.42M | Buy |
+28,209
| New | +$2.18M | 0.14% | 166 |
|
|
2017
Q4 | – | Sell |
-3,268
| Closed | -$189K | – | 2102 |
|
|
2017
Q3 | $189K | Buy |
+3,268
| New | +$193K | 0.01% | 1473 |
|
|
2017
Q1 | – | Sell |
-3,800
| Closed | -$233K | – | 1883 |
|
|
2016
Q4 | $233K | Buy |
+3,800
| New | +$248K | 0.02% | 1151 |
|
|
2016
Q3 | – | Sell |
-5,476
| Closed | -$305K | – | 1887 |
|
|
2016
Q2 | $305K | Buy |
+5,476
| New | +$330K | 0.02% | 1078 |
|
|
2016
Q1 | – | Sell |
-6,294
| Closed | -$402K | – | 1847 |
|
|
2015
Q4 | $402K | Sell |
6,294
-1,002
| -14% | -$65K | 0.02% | 942 |
|
|
2015
Q3 | $489K | Buy |
+7,296
| New | +$516K | 0.02% | 970 |
|
|
2015
Q1 | – | Sell |
-5,544
| Closed | -$284K | – | 2088 |
|
|
2014
Q4 | $284K | Buy |
+5,544
| New | +$272K | 0.02% | 1264 |
|
Other funds holding USNA
Cubist Systematic Strategies's USNA Position: Q3 2024 in Review
Cubist Systematic Strategies sold out of Usana Health Sciences (USNA) in Q3 2024, closing a stake of 11,822 shares — an estimated $535K sold.
Cubist Systematic Strategies first reported a position in USNA in Q4 2014 and held it in 30 quarters. The position peaked at $4.2M in Q2 2020. 147 funds tracked by Wall St. Rank hold USNA as of Q3 2024.
- Cubist Systematic Strategies reported no remaining Usana Health Sciences position as of Q3 2024 after selling out during the quarter.
- Cubist Systematic Strategies sold 11,822 Usana Health Sciences shares in Q3 2024, an estimated $535K.
- Cubist Systematic Strategies first reported a position in Usana Health Sciences in Q4 2014 and held it in 30 quarters.
- Cubist Systematic Strategies's Usana Health Sciences position peaked at $4.2M in Q2 2020.
- 147 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2024.
Based on Cubist Systematic Strategies's 13F filing for Q3 2024, filed 14 Nov 2024.